The American Civil Liberties Union (ACLU) said on Tuesday as part of a settlemen…
Original article by Reuters Editorial
Author: Lars
View all posts by Lars
Lars has recently written 8 articles on similar topics including :
"A number of concerns have been raised about content moderation and censorship in traditional social media that decentralization might solve" . (September 8, 2023 )"Facebook says that it accidentally deleted some of Mark Zuckerberg's posts, and it doesn't expect to restore them" . (March 31, 2019 )"The number you gave Facebook for 2FA? Yeah, they don't just use it for security" . (March 18, 2019 )"As Facebook marks its 15th birthday, WIRED Magazine is highlighting "15 moments that defined Facebook's first 15 years." CBS News contributor and Wired senior writer Issie Lapowsky joins CBSN to discuss" . (February 5, 2019 )"Users are complaining that the phone number Facebook hassled them to use to secure their account with two-factor authentication has also been associated with their user profile — which anyone can use to “look up” your profile" . (March 4, 2019 )"A privacy complaint targeting the behavioral advertising industry has a new piece of evidence that shows the Internet Advertising Bureau (IAB) shedding doubt on whether it’s possible to obtain informed consent from web users for the programmatic ad industry’s real-time bidding (RTB) sys…" . (February 21, 2019 )"Two of Facebook's four fact-checking partners in the U.S. have left the program as of the beginning of this year: Snopes, which recently rebuffed reports that its relationship with Facebook was strained, and the Associated Press" . (February 2, 2019 )"Aridor, chairman of the board of AEBi and CEO Dr. Ilan Morad, say the AEBi anti-cancer treatment, which they call MuTaTo (multi-target toxin) is essentially on the scale of a cancer antibiotic – a disruption technology of the highest order. They are using peptides. MuTaTo is using a combination of several cancer-targeting peptides for each cancer cell at the same time, combined with a strong peptide toxin that would kill cancer cells specifically. By using at least three targeting peptides on the same structure with a strong toxin, AEBi made sure that the treatment will not be affected by mutations" . (January 29, 2019 )
Posted on March 19, 2019 June 24, 2019 advertisers , civil liberties , facebook , fundamental rights , internet , labour , personnel , publishing , race relations , social media , technology , telecoms , united states , world wide web
